Previous
Next
adhd study results mom son homework

ADHD symptom control from a liquid non-stimulant

Effective when combined with a stimulant or when used alone

Efficacy in combination with stimulant

When added to stimulant therapy, clonidine XR showed up to 37% improvement over placebo in ADHD-RS-IV scores. ONYDA XR can improve ADHD symptom control in patients treated with stimulants.

CLINICAL STUDY
6 to 17 years old children with ADHD who had been treated with stimulants and had inadequate response were assigned to 1 of 2 treatment groups
Baseline stimulant medication + clonidine XR

Baseline stimulant medication
+ clonidine XR

Baseline stimulant medication + placebo

Baseline stimulant medication
+ placebo

During the 8 week study, patients took either clonidine XR or a placebo, in addition to their regular stimulant medication. The clonidine XR dose was gradually titrated based on patients' response to treatment.

WEEKLY ASSESSMENTS
clipboard icon

Each week, researchers measured changes in the child's inattention and hyperactivity/impulsivity using a standard ADHD rating scale (ADHD-RS-IV)

at 5 weeks icon
5 week icon

At week 5, patients in the stimulant + clonidine XR group had significantly greater improvement in inattention and hyperactivity/impulsivity scores from baseline than those taking stimulant + placebo.


The most common adverse events in the study were somnolence, fatigue, headache, upper abdominal pain, nasal congestion, pharyngolaryngeal pain, cough, irritability, insomnia, dizziness, and increased body temperature.

STUDY RESULTS
bottle icon

Adding clonidine XR to a stimulant improved ADHD symptoms more than a stimulant alone

Adding ONYDA XR may help improve ADHD symptom control in patients

Efficacy as monotherapy

Studies of clonidine XR showed improvement over placebo in ADHD-RS-IV scores. ONYDA XR can improve symptom control in patients.

CLINICAL STUDY
6 to 17 year old children with ADHD were randomly assigned to 1 of 3 treatment groups
Baseline stimulant medication + clonidine XR

Clonidine XR
0.2 mg/day

Baseline stimulant medication + clonidine XR

Clonidine XR
0.4 mg/day

Baseline stimulant medication + placebo

Placebo
No active medicine

During the 8 week study, patients took either clonidine XR or a placebo. The clonidine XR dose was slowly increased over time until each patient reached their assigned dose.

WEEKLY ASSESSMENTS
clipboard icon

Each week, researchers measured changes in the child's inattention and hyperactivity/impulsivity using a standard ADHD rating scale (ADHD-RS-IV)

at 5 weeks icon
5 week icon

At week 5, patients in the clonidine XR groups had significantly greater improvement in inattention and hyperactivity/impulsivity scores from baseline than those in the placebo group.


The most common adverse events in the study were somnolence, fatigue, irritability, pharyngolaryngeal pain, increased body temperature, ear pain, emotional disorder, nightmare, insomnia, constipation and dry mouth.

STUDY RESULTS
clipboard icon

Studies of clonidine XR showed improvement over placebo in ADHD-RS-IV scores

ONYDA XR may help improve ADHD symptom control in patients

Savings & Support

We want to make getting ONYDA XR as easy and inexpensive as possible! Learn about your options below!

ONYDA Savings card
Eligible patients pay $25 per month with the Tris Savings Program

8 out of 10 of commercially covered patients pay $25

Get Savings Card

Or text TRIS to TRIS4U (874748) for a Mobile Savings Card§

ScriptsRX Logo
Eligible commercially-insured patients
pay as little as $15

You’ll also receive free delivery, automatic refills, same-day processing, and ongoing support.

Learn More

Stay in the know with all things ONYDA XR

Join the ONYDA XR Community to receive monthly emails about ONYDA XR and resources to help support your child's ADHD treatment journey.

* Terms and Conditions apply.
** Mobile Terms and Conditions: TrisSavingsCard.com/terms. Message data rates may apply.

REFERENCES: 1. ONYDA XR [package insert]. Tris Pharma, Inc., Monmouth Junction, NJ. 2. Jain R, Segal S, Kollins SH, Khayrallah M. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171-9. 3. Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB, Khayrallah M. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics. 2011 Jun;127(6):e1406-13.

BACK TO TOP arrow up

Important Safety Information

ONYDA XR is a prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) alone or with certain other ADHD medicines in children 6 years of age and older.

It is not known if ONYDA XR is safe and effective in children under 6 years of age.

See Additional Important Safety Information.

APPROVED USE

ONYDA® XR (clonidine HCI) is a prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), alone or with certain other ADHD medicines, in children 6 years of age and older. It is not known if ONYDA XR is safe and effective in children under 6 years of age.

Important Safety Information

Do not take ONYDA XR if you are allergic to clonidine.

Before taking ONYDA XR, tell your healthcare provider if you have kidney problems; low or high blood pressure; a history of passing out (syncope); heart problems (including slow heart rate or rhythm problems); had a stroke or stroke symptoms; or had an allergic reaction after taking clonidine through the skin (patch). Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. It is not known if ONYDA XR may harm an unborn baby. ONYDA XR passes into breast milk and may cause sleepiness, floppy muscles, or breathing problems in breastfed babies. A pregnancy registry is available at 1-866-961-2388 or womensmentalhealth.org/adhdmedications.

Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ONYDA XR may interact with medicines for depression, ADHD, heart or blood pressure conditions, medicines that cause sleepiness, or other clonidine-containing medicines.

What to avoid while taking ONYDA XR?

Avoid dehydration and overheating, which may increase the risk of passing out.

Do not drive, operate machinery, or perform dangerous activities until you know how ONYDA XR affects you, because it may cause sleepiness and tiredness that can slow reaction times.

Avoid alcohol or other medicines that cause sleepiness or dizziness unless discussed with your healthcare provider.

Do not suddenly stop ONYDA XR. Stopping suddenly may cause rebound high blood pressure and withdrawal symptoms. Contact your healthcare provider before stopping treatment. If vomiting prevents you from taking ONYDA XR, contact your healthcare provider because rebound hypertension may occur.

Possible side effects

ONYDA XR may cause serious side effects including:

Low blood pressure and slow heart rate, which may increase the risk of passing out. Your healthcare provider should check your heart rate and blood pressure before and during treatment.

Sleepiness and tiredness that may slow reaction times.

Rebound high blood pressure and withdrawal symptoms after sudden stop (including headache, increased heart rate, nausea, flushing or warm feeling, lightheadedness, chest tightness, nervousness, or anxiety).

Allergic reactions. Stop taking ONYDA XR and seek medical help immediately if you develop rash, hives, or swelling of the eyes, face, lips, or tongue, especially if you previously had an allergic reaction to clonidine patch.

ONYDA XR may cause fertility problems in females and males, which may affect the ability to have a child. Talk to your healthcare provider if this is a concern.

Most common side effects when used alone:

Sleepiness/tiredness, nightmare, constipation, irritability, trouble sleeping, and dry mouth.

Most common side effects when used with other ADHD medicines:

Sleepiness/tiredness, decreased appetite, and dizziness.

These are not all possible side effects of ONYDA XR. Call your healthcare provider for medical advice about side effects. Report side effects to Tris Pharma, Inc. at 1-732-940-0358 or FDA at 1-800-FDA-1088.

Please see Full Prescribing Information and Patient Information, including Instructions for Use.

up arrowTop